Redmile Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,740
| Closed | -$247K | – | 72 |
|
|
2019
Q3 | $247K | Hold |
2,740
| – | – | 0.01% | 67 |
|
|
2019
Q2 | $231K | Buy |
+2,740
| New | +$231K | 0.01% | 76 |
|
|
2017
Q4 | – | Sell |
-6,640
| Closed | -$407K | – | 77 |
|
|
2017
Q3 | $407K | Hold |
6,640
| – | – | 0.02% | 59 |
|
|
2017
Q2 | $305K | Sell |
6,640
-615,705
| -99% | -$28.3M | 0.02% | 55 |
|
|
2017
Q1 | $26.9M | Buy |
+622,345
| New | +$26.9M | 1.75% | 22 |
|
|
2013
Q3 | – | Sell |
-580,500
| Closed | -$7.77M | – | 56 |
|
|
2013
Q2 | $7.77M | Buy |
+580,500
| New | +$7.77M | 1.37% | 28 |
|